Surgical Treatment of an Endolymphatic Sac Tumor

J Vis Exp. 2023 May 26:(195). doi: 10.3791/65079.

Abstract

Endolymphatic sac tumors (ELST) are low-grade papillary adenocarcinoma originating from the endolymphatic sac. Usually slow-growing, with local aggressiveness and a low risk of distant metastases, ELST can be sporadic but also frequently associated with von Hippel Lindau disease. The current treatment of ELST is primarily surgical resection. A 55-year-old woman accessed our otologic tertiary level referral center for a sudden worsening of hearing loss in her left ear and vertigo. A magnetic resonance (MRI) and computer tomography scan study subsequently showed a mass in the petrous bone; hence, the presence of an ELST was hypothesized. After embolization of the mass, the patient underwent surgical removal of the lesion. The resection of the mass was done through a translabirinthine approach, with an uneventful procedure. No residual disease remained after surgery. After 24 months of radiologic follow up with MRI, there are no signs of recurrence disease. This paper reports the management of this sporadic ELST, as well as the follow up results, providing clinicians this protocol for the handling of such a challenging otologic skull base surgery and rare disease.

Publication types

  • Case Reports
  • Video-Audio Media

MeSH terms

  • Adenocarcinoma, Papillary*
  • Adenoma*
  • Bone Neoplasms*
  • Endolymphatic Sac*
  • Female
  • Humans
  • Middle Aged
  • Neurosurgical Procedures
  • Vertigo